Entera Bio logo

Entera Bio

ENTX | NASDAQ
Chart Builder DCF Calculator
$3.02
-$0.09 (-2.89%)
At close: Nov 16, 2026, 4:00 PM ET
$2.93
-$0.09 (-2.98%)
After-hours: Nov 16, 2026, 7:03 PM ET
-2.89%

Rating

Updated: Nov 16, 2026
29.2
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #827/1021 (Top 81%)

Key Statistics

Market Data

Market Cap $525.9M
1D Range
3.00 3.12
52W Range
1.00 3.92

Valuation (TTM)

PE -17.76
PB 1.92
EV/EBITDA -23.54

Valuation (NTM)

Forward PE N/A
Forward PEG -0.10
Price Target $9.00
Loading financial charts...

Profile

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that curr...

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Jun 28, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$9.00
Upside
+198.01%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.